Share Price and Basic Stock Data
Last Updated: October 18, 2025, 7:42 pm
| PEG Ratio | 1.46 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Balgopal Commercial Ltd, operating in the trading and distribution industry, reported a share price of ₹231 and a market capitalization of ₹439 Cr. Over the past quarters, the company’s revenue has shown significant fluctuation. For instance, sales stood at ₹1.17 Cr in June 2022, peaked at ₹8.92 Cr by December 2023, but then dropped to ₹0.05 Cr in June 2024. The overall trend indicates a notable spike in sales in September 2023 at ₹6.03 Cr, followed by another increase to ₹8.92 Cr in December 2023. However, the company also experienced a decline in the subsequent quarters of FY 2025, with revenue dropping to ₹0.00 Cr by March 2025. This inconsistent revenue pattern raises questions about operational stability and market demand for Balgopal’s offerings.
Profitability and Efficiency Metrics
In terms of profitability, Balgopal Commercial Ltd reported a net profit of ₹6.34 Cr for the fiscal year ending March 2025, with an earnings per share (EPS) of ₹3.70. The operating profit margin (OPM) showed a remarkable improvement, rising to 1320.40% in FY 2025, indicating effective cost management during this period. The return on equity (ROE) stood at 12.6%, while the return on capital employed (ROCE) was recorded at 14.8%. However, the company reported significant fluctuations in operating profit across various quarters, with a negative OPM of -340.00% in June 2024. This inconsistency in profitability metrics suggests potential operational challenges that could impact long-term financial health.
Balance Sheet Strength and Financial Ratios
Balgopal’s balance sheet reflects a strong position with no borrowings reported, maintaining a debt-to-equity ratio of 0.02, indicating low financial leverage. Reserves have increased significantly to ₹37.65 Cr as of March 2025, up from negative reserves in previous years. The current ratio stands at 3.40, illustrating a solid liquidity position, while the quick ratio is at 1.66, suggesting the company can meet short-term obligations comfortably. The price-to-book value ratio is relatively high at 5.48x, which may imply that the stock is trading at a premium compared to its book value. The asset turnover ratio remains low at 0.00%, indicating potential inefficiencies in utilizing assets to generate sales.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Balgopal Commercial Ltd indicates a significant shift in promoter ownership, which rose from 6.31% in September 2022 to 45.42% by June 2025. This increase in promoter stake may reflect confidence in the company’s future prospects. Conversely, public shareholding decreased from 93.69% in September 2022 to 54.56% in June 2025, suggesting that public investors may be reducing their stakes amid volatility in performance. The number of shareholders has also shown growth, increasing from 523 in September 2022 to 1,386 in June 2025, indicating rising interest from a broader investor base. This dynamic could signal a positive shift in investor sentiment, though the declining public shareholding could raise concerns about market confidence.
Outlook, Risks, and Final Insight
If margins sustain their recent improvements, Balgopal Commercial Ltd could enhance its profitability and operational stability. However, the company’s erratic sales performance poses a substantial risk, particularly if the downturn in revenue continues. The absence of debt provides a buffer against financial strain, yet the high price-to-book ratio may deter potential investors seeking value. Additionally, the fluctuating shareholding pattern could impact market perception and investor confidence. While the increase in reserves is a positive sign, the reliance on trading and distribution could expose the company to market volatility. Addressing these risks through enhanced operational efficiency and consistent revenue generation will be crucial for Balgopal’s sustained growth.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Balgopal Commercial Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minal Industries Ltd | 67.9 Cr. | 3.54 | 5.59/3.20 | 40.4 | 2.77 | 0.00 % | 5.97 % | 2.83 % | 2.00 |
| Mitshi India Ltd | 13.8 Cr. | 15.7 | 19.5/13.0 | 461 | 3.09 | 0.00 % | 0.36 % | 0.37 % | 10.0 |
| Modella Woollens Ltd | 6.33 Cr. | 69.6 | 74.2/52.5 | 3.63 | 0.00 % | % | % | 10.0 | |
| MRC Agrotech Ltd | 82.3 Cr. | 40.2 | 44.4/10.2 | 81.5 | 15.0 | 0.00 % | 5.89 % | 4.46 % | 10.0 |
| MRP Agro Ltd | 110 Cr. | 99.0 | 174/84.4 | 14.8 | 29.3 | 0.00 % | 39.2 % | 30.3 % | 10.0 |
| Industry Average | 11,952.30 Cr | 168.40 | 105.10 | 113.39 | 0.26% | 15.73% | 9.23% | 7.74 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.17 | 3.93 | 2.01 | 1.08 | 1.00 | 6.03 | 8.92 | 1.09 | 0.05 | 0.33 | 0.18 | 0.00 | 0.00 |
| Expenses | 1.12 | 3.81 | 2.00 | 1.17 | 0.97 | 4.62 | 7.69 | 1.39 | 0.22 | 0.24 | 0.45 | 0.36 | 0.30 |
| Operating Profit | 0.05 | 0.12 | 0.01 | -0.09 | 0.03 | 1.41 | 1.23 | -0.30 | -0.17 | 0.09 | -0.27 | -0.36 | -0.30 |
| OPM % | 4.27% | 3.05% | 0.50% | -8.33% | 3.00% | 23.38% | 13.79% | -27.52% | -340.00% | 27.27% | -150.00% | ||
| Other Income | 0.04 | 1.84 | 1.87 | -3.81 | 2.07 | 2.74 | 2.74 | 4.23 | 4.69 | 7.93 | 0.17 | -4.65 | 2.34 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.09 | 1.96 | 1.88 | -3.90 | 2.10 | 4.15 | 3.97 | 3.93 | 4.52 | 8.02 | -0.10 | -5.01 | 2.04 |
| Tax % | -377.78% | 10.71% | 5.85% | -3.08% | 23.33% | 0.72% | 6.80% | 5.09% | 14.16% | 11.35% | 170.00% | -12.57% | 17.65% |
| Net Profit | 0.43 | 1.75 | 1.77 | -3.78 | 1.61 | 4.11 | 3.70 | 3.74 | 3.88 | 7.10 | -0.27 | -4.38 | 1.68 |
| EPS in Rs | 0.26 | 1.06 | 1.07 | -2.29 | 0.98 | 2.49 | 2.24 | 2.27 | 2.35 | 4.30 | -0.16 | -2.30 | 0.88 |
Last Updated: August 19, 2025, 10:45 pm
Below is a detailed analysis of the quarterly data for Balgopal Commercial Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Expenses, as of Jun 2025, the value is 0.30 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.36 Cr. (Mar 2025) to 0.30 Cr., marking a decrease of 0.06 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.30 Cr.. The value appears strong and on an upward trend. It has increased from -0.36 Cr. (Mar 2025) to -0.30 Cr., marking an increase of 0.06 Cr..
- For OPM %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Other Income, as of Jun 2025, the value is 2.34 Cr.. The value appears strong and on an upward trend. It has increased from -4.65 Cr. (Mar 2025) to 2.34 Cr., marking an increase of 6.99 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 2.04 Cr.. The value appears strong and on an upward trend. It has increased from -5.01 Cr. (Mar 2025) to 2.04 Cr., marking an increase of 7.05 Cr..
- For Tax %, as of Jun 2025, the value is 17.65%. The value appears to be increasing, which may not be favorable. It has increased from -12.57% (Mar 2025) to 17.65%, marking an increase of 30.22%.
- For Net Profit, as of Jun 2025, the value is 1.68 Cr.. The value appears strong and on an upward trend. It has increased from -4.38 Cr. (Mar 2025) to 1.68 Cr., marking an increase of 6.06 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.88. The value appears strong and on an upward trend. It has increased from -2.30 (Mar 2025) to 0.88, marking an increase of 3.18.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:49 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.81 | 3.81 | 2.60 | 4.57 | 14.80 | 16.40 | 9.61 | 5.36 | 8.00 | 8.19 | 17.05 | 0.56 | 0.51 |
| Expenses | 0.80 | 4.13 | 3.00 | 5.22 | 15.97 | 19.79 | 18.16 | 6.13 | 8.55 | 8.00 | 14.69 | 1.27 | 1.35 |
| Operating Profit | 0.01 | -0.32 | -0.40 | -0.65 | -1.17 | -3.39 | -8.55 | -0.77 | -0.55 | 0.19 | 2.36 | -0.71 | -0.84 |
| OPM % | 1.23% | -8.40% | -15.38% | -14.22% | -7.91% | -20.67% | -88.97% | -14.37% | -6.88% | 2.32% | 13.84% | -126.79% | -164.71% |
| Other Income | 0.00 | 0.40 | 0.45 | 0.70 | 0.82 | 1.29 | 1.57 | 7.52 | 0.92 | -0.05 | 11.79 | 8.14 | 5.79 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.01 | 0.08 | 0.05 | 0.05 | -0.35 | -2.10 | -6.98 | 6.75 | 0.37 | 0.04 | 14.15 | 7.43 | 4.95 |
| Tax % | 0.00% | 25.00% | 40.00% | 20.00% | -8.57% | 6.19% | -8.17% | 14.52% | 18.92% | -350.00% | 7.00% | 14.67% | |
| Net Profit | 0.00 | 0.06 | 0.03 | 0.05 | -0.32 | -2.24 | -6.42 | 5.77 | 0.30 | 0.17 | 13.17 | 6.34 | 4.13 |
| EPS in Rs | 0.00 | 0.04 | 0.02 | 0.03 | -0.19 | -1.36 | -3.89 | 3.49 | 0.18 | 0.10 | 7.98 | 3.34 | 2.72 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -50.00% | 66.67% | -740.00% | -600.00% | -186.61% | 189.88% | -94.80% | -43.33% | 7647.06% | -51.86% |
| Change in YoY Net Profit Growth (%) | 0.00% | 116.67% | -806.67% | 140.00% | 413.39% | 376.48% | -284.68% | 51.47% | 7690.39% | -7698.92% |
Balgopal Commercial Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -17% |
| 5 Years: | -43% |
| 3 Years: | -59% |
| TTM: | -97% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 59% |
| 5 Years: | 24% |
| 3 Years: | 185% |
| TTM: | -73% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 137% |
| 1 Year: | 165% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 12% |
| 3 Years: | 10% |
| Last Year: | 15% |
Last Updated: September 5, 2025, 2:36 pm
Balance Sheet
Last Updated: October 10, 2025, 3:35 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.24 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 19.01 |
| Reserves | 17.75 | 1.54 | 1.57 | 1.61 | 1.29 | -0.95 | -7.36 | -1.59 | -1.27 | -1.10 | 12.07 | 37.65 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.00 | 4.24 | 0.02 | 0.46 | 0.47 | 0.11 | 0.39 | 1.35 | 3.53 | 2.23 | 6.17 | 7.81 |
| Total Liabilities | 17.99 | 22.29 | 18.10 | 18.58 | 18.27 | 15.67 | 9.54 | 16.52 | 18.77 | 17.64 | 34.75 | 64.47 |
| Fixed Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 7.42 | 2.40 | 5.79 | 7.42 | 3.60 | 4.28 | 4.48 | 11.44 | 16.89 | 7.28 | 21.09 | 40.03 |
| Other Assets | 10.57 | 19.89 | 12.31 | 11.16 | 14.67 | 11.39 | 5.06 | 5.08 | 1.88 | 10.36 | 13.66 | 24.44 |
| Total Assets | 17.99 | 22.29 | 18.10 | 18.58 | 18.27 | 15.67 | 9.54 | 16.52 | 18.77 | 17.64 | 34.75 | 64.47 |
Below is a detailed analysis of the balance sheet data for Balgopal Commercial Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 19.01 Cr.. The value appears strong and on an upward trend. It has increased from 16.51 Cr. (Mar 2024) to 19.01 Cr., marking an increase of 2.50 Cr..
- For Reserves, as of Mar 2025, the value is 37.65 Cr.. The value appears strong and on an upward trend. It has increased from 12.07 Cr. (Mar 2024) to 37.65 Cr., marking an increase of 25.58 Cr..
- For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 7.81 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.17 Cr. (Mar 2024) to 7.81 Cr., marking an increase of 1.64 Cr..
- For Total Liabilities, as of Mar 2025, the value is 64.47 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 34.75 Cr. (Mar 2024) to 64.47 Cr., marking an increase of 29.72 Cr..
- For Fixed Assets, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 40.03 Cr.. The value appears strong and on an upward trend. It has increased from 21.09 Cr. (Mar 2024) to 40.03 Cr., marking an increase of 18.94 Cr..
- For Other Assets, as of Mar 2025, the value is 24.44 Cr.. The value appears strong and on an upward trend. It has increased from 13.66 Cr. (Mar 2024) to 24.44 Cr., marking an increase of 10.78 Cr..
- For Total Assets, as of Mar 2025, the value is 64.47 Cr.. The value appears strong and on an upward trend. It has increased from 34.75 Cr. (Mar 2024) to 64.47 Cr., marking an increase of 29.72 Cr..
Notably, the Reserves (37.65 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.01 | -0.32 | -0.40 | -0.65 | -1.17 | -3.39 | -8.55 | -1.02 | -0.55 | 0.19 | 2.36 | -0.71 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 365.00 | 233.75 | 4.21 | 112.61 | 195.57 | 107.94 | 109.01 | 121.89 | 15.06 | 25.85 | 0.00 | 0.00 |
| Inventory Days | 2,737.50 | 780.21 | 1,056.29 | 411.08 | 114.63 | 61.12 | 0.00 | 47.74 | 68.23 | 280.44 | 14.79 | |
| Days Payable | 0.00 | 407.49 | 0.00 | 32.92 | 11.15 | 0.00 | 46.27 | 97.68 | 88.38 | 0.00 | ||
| Cash Conversion Cycle | 3,102.50 | 606.48 | 1,060.50 | 490.78 | 299.04 | 169.06 | 109.01 | 123.36 | -14.39 | 217.90 | 14.79 | 0.00 |
| Working Capital Days | 4,763.02 | 1,491.61 | 1,715.50 | 852.20 | 349.22 | 251.94 | 158.76 | 264.90 | -53.84 | 365.45 | 160.34 | 6,537.41 |
| ROCE % | 0.06% | 0.44% | 0.28% | 0.28% | -1.11% | -12.59% | -56.50% | 55.51% | -1.97% | -16.64% | 17.50% | 14.81% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 15 | Mar 14 |
|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.70 | 0.04 | 0.12 |
| Diluted EPS (Rs.) | 3.52 | 0.04 | 0.12 |
| Cash EPS (Rs.) | 3.31 | 0.03 | 0.15 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 29.77 | 10.99 | 757.55 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 29.77 | 10.99 | 757.55 |
| Revenue From Operations / Share (Rs.) | 0.29 | 2.56 | 33.95 |
| PBDIT / Share (Rs.) | 3.88 | 0.04 | 0.22 |
| PBIT / Share (Rs.) | 3.88 | 0.04 | 0.19 |
| PBT / Share (Rs.) | 3.88 | 0.04 | 0.19 |
| Net Profit / Share (Rs.) | 3.31 | 0.03 | 0.11 |
| NP After MI And SOA / Share (Rs.) | 3.31 | 0.03 | 0.11 |
| PBDIT Margin (%) | 1320.40 | 1.84 | 0.66 |
| PBIT Margin (%) | 1320.40 | 1.84 | 0.56 |
| PBT Margin (%) | 1320.40 | 1.84 | 0.56 |
| Net Profit Margin (%) | 1125.53 | 1.39 | 0.34 |
| NP After MI And SOA Margin (%) | 1125.53 | 1.39 | 0.34 |
| Return on Networth / Equity (%) | 11.12 | 0.32 | 0.01 |
| Return on Capital Employeed (%) | 12.50 | 0.42 | 0.02 |
| Return On Assets (%) | 9.49 | 0.26 | 0.01 |
| Long Term Debt / Equity (X) | 0.02 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.02 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.00 | 0.20 | 0.00 |
| Current Ratio (X) | 3.40 | 4.69 | 3112.46 |
| Quick Ratio (X) | 1.66 | 2.79 | 1349.68 |
| Enterprise Value (Cr.) | 308.25 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 551.24 | 0.00 | 0.00 |
| EV / EBITDA (X) | 41.75 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 554.80 | 0.00 | 0.00 |
| Price / BV (X) | 5.48 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 555.10 | 0.00 | 0.00 |
| EarningsYield | 0.02 | 0.00 | 0.00 |
After reviewing the key financial ratios for Balgopal Commercial Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 15) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.70. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 15) to 3.70, marking an increase of 3.66.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.52. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 15) to 3.52, marking an increase of 3.48.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.31. This value is within the healthy range. It has increased from 0.03 (Mar 15) to 3.31, marking an increase of 3.28.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.77. It has increased from 10.99 (Mar 15) to 29.77, marking an increase of 18.78.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.77. It has increased from 10.99 (Mar 15) to 29.77, marking an increase of 18.78.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.29. It has decreased from 2.56 (Mar 15) to 0.29, marking a decrease of 2.27.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 3.88. This value is within the healthy range. It has increased from 0.04 (Mar 15) to 3.88, marking an increase of 3.84.
- For PBIT / Share (Rs.), as of Mar 25, the value is 3.88. This value is within the healthy range. It has increased from 0.04 (Mar 15) to 3.88, marking an increase of 3.84.
- For PBT / Share (Rs.), as of Mar 25, the value is 3.88. This value is within the healthy range. It has increased from 0.04 (Mar 15) to 3.88, marking an increase of 3.84.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.31. This value is within the healthy range. It has increased from 0.03 (Mar 15) to 3.31, marking an increase of 3.28.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.31. This value is within the healthy range. It has increased from 0.03 (Mar 15) to 3.31, marking an increase of 3.28.
- For PBDIT Margin (%), as of Mar 25, the value is 1,320.40. This value is within the healthy range. It has increased from 1.84 (Mar 15) to 1,320.40, marking an increase of 1,318.56.
- For PBIT Margin (%), as of Mar 25, the value is 1,320.40. This value exceeds the healthy maximum of 20. It has increased from 1.84 (Mar 15) to 1,320.40, marking an increase of 1,318.56.
- For PBT Margin (%), as of Mar 25, the value is 1,320.40. This value is within the healthy range. It has increased from 1.84 (Mar 15) to 1,320.40, marking an increase of 1,318.56.
- For Net Profit Margin (%), as of Mar 25, the value is 1,125.53. This value exceeds the healthy maximum of 10. It has increased from 1.39 (Mar 15) to 1,125.53, marking an increase of 1,124.14.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1,125.53. This value exceeds the healthy maximum of 20. It has increased from 1.39 (Mar 15) to 1,125.53, marking an increase of 1,124.14.
- For Return on Networth / Equity (%), as of Mar 25, the value is 11.12. This value is below the healthy minimum of 15. It has increased from 0.32 (Mar 15) to 11.12, marking an increase of 10.80.
- For Return on Capital Employeed (%), as of Mar 25, the value is 12.50. This value is within the healthy range. It has increased from 0.42 (Mar 15) to 12.50, marking an increase of 12.08.
- For Return On Assets (%), as of Mar 25, the value is 9.49. This value is within the healthy range. It has increased from 0.26 (Mar 15) to 9.49, marking an increase of 9.23.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 15) to 0.02, marking an increase of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has increased from 0.00 (Mar 15) to 0.02, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. It has decreased from 0.20 (Mar 15) to 0.00, marking a decrease of 0.20.
- For Current Ratio (X), as of Mar 25, the value is 3.40. This value exceeds the healthy maximum of 3. It has decreased from 4.69 (Mar 15) to 3.40, marking a decrease of 1.29.
- For Quick Ratio (X), as of Mar 25, the value is 1.66. This value is within the healthy range. It has decreased from 2.79 (Mar 15) to 1.66, marking a decrease of 1.13.
- For Enterprise Value (Cr.), as of Mar 25, the value is 308.25. It has increased from 0.00 (Mar 15) to 308.25, marking an increase of 308.25.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 551.24. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 15) to 551.24, marking an increase of 551.24.
- For EV / EBITDA (X), as of Mar 25, the value is 41.75. This value exceeds the healthy maximum of 15. It has increased from 0.00 (Mar 15) to 41.75, marking an increase of 41.75.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 554.80. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 15) to 554.80, marking an increase of 554.80.
- For Price / BV (X), as of Mar 25, the value is 5.48. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 15) to 5.48, marking an increase of 5.48.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 555.10. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 15) to 555.10, marking an increase of 555.10.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 15) to 0.02, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Balgopal Commercial Ltd:
- Net Profit Margin: 1125.53%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12.5% (Industry Average ROCE: 15.73%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 11.12% (Industry Average ROE: 9.23%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.66
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 105 (Industry average Stock P/E: 105.1)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.02
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1125.53%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Trading & Distributors | Flat No. B-002, Dreamax Vega, Upadhyay Compound, Pump House, Mumbai Maharashtra 400093 | info@bcommercial.org http://www.bcommercial.org |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Vijay Laltaprasad Yadav | Managing Director |
| Mr. Yash Saraogi | Non Executive Director |
| Mrs. Shrena Kalpesh Shah | Ind. Non-Executive Director |
| Ms. Shailesh Becharbhai Patel | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Balgopal Commercial Ltd?
Balgopal Commercial Ltd's intrinsic value (as of 19 October 2025) is 321.71 which is 40.48% higher the current market price of 229.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 435 Cr. market cap, FY2025-2026 high/low of 273/52.8, reserves of ₹37.65 Cr, and liabilities of 64.47 Cr.
What is the Market Cap of Balgopal Commercial Ltd?
The Market Cap of Balgopal Commercial Ltd is 435 Cr..
What is the current Stock Price of Balgopal Commercial Ltd as on 19 October 2025?
The current stock price of Balgopal Commercial Ltd as on 19 October 2025 is 229.
What is the High / Low of Balgopal Commercial Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Balgopal Commercial Ltd stocks is 273/52.8.
What is the Stock P/E of Balgopal Commercial Ltd?
The Stock P/E of Balgopal Commercial Ltd is 105.
What is the Book Value of Balgopal Commercial Ltd?
The Book Value of Balgopal Commercial Ltd is 29.8.
What is the Dividend Yield of Balgopal Commercial Ltd?
The Dividend Yield of Balgopal Commercial Ltd is 0.00 %.
What is the ROCE of Balgopal Commercial Ltd?
The ROCE of Balgopal Commercial Ltd is 14.8 %.
What is the ROE of Balgopal Commercial Ltd?
The ROE of Balgopal Commercial Ltd is 12.6 %.
What is the Face Value of Balgopal Commercial Ltd?
The Face Value of Balgopal Commercial Ltd is 10.0.